Medical Decision Making

1981 - 2025

Bibliographic data for series maintained by SAGE Publications ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 37, issue 8, 2017

Déjà Vu: Introducing Operations Research to Health Care pp. 847-848

Todd H. Wagner and Jeffrey K. Jopling

From Data to Improved Decisions: Operations Research in Healthcare Delivery pp. 849-859

Muge Capan, Anahita Khojandi, Brian T. Denton, Kimberly D. Williams, Turgay Ayer, Jagpreet Chhatwal, Murat Kurt, Jennifer Mason Lobo, Mark S. Roberts, Greg Zaric, Shengfan Zhang and J. Sanford Schwartz

Effects of Anti- Versus Pro-Vaccine Narratives on Responses by Recipients Varying in Numeracy: A Cross-sectional Survey-Based Experiment pp. 860-870

Wändi Bruine de Bruin, Annika Wallin, Andrew M. Parker, JoNell Strough and Janel Hanmer

The Effect of Individual Movements and Interventions on the Spread of Influenza in Long-Term Care Facilities pp. 871-881

Mehdi Najafi, Marek Laskowski, Pieter T. de Boer, Evelyn Williams, Ayman Chit and Seyed M. Moghadas

A Comparison of the Validity and Responsiveness of the EQ-5D-5L and SF-6D for Measuring Health Spillovers: A Study of the Family Impact of Meningitis pp. 882-893

Arjun Bhadhuri, Sue Jowett, Kate Jolly and Hareth Al-Janabi

The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis pp. 894-904

Chris Cameron, Emmanuel Ewara, Florence R. Wilson, Abhishek Varu, Peter Dyrda, Brian Hutton and Michael Ingham

A Framework for Treatment Decision Making at Prostate Cancer Recurrence pp. 905-913

Jane M. Lange, Bruce J. Trock, Roman Gulati and Ruth Etzioni

Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease pp. 914-921

Ryan M. Antiel, Scott D. Halpern, Evelyn M. Stevens, Jesse D. Vrecenak, Chavis A. Patterson, Trudy Tchume-Johnson, Kim Smith-Whitley, William H. Peranteau, Alan W. Flake and Lamia P. Barakat

Taking Costs and Diagnostic Test Accuracy into Account When Designing Prevalence Studies: An Application to Childhood Tuberculosis Prevalence pp. 922-929

Zhuoyu Wang, Nandini Dendukuri, Madhukar Pai and Lawrence Joseph

New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives pp. 930-941

David D. Kim and Anirban Basu

Does Guiding Toward Task-Relevant Information Help Improve Graph Processing and Graph Comprehension of Individuals with Low or High Numeracy? An Eye-Tracker Experiment pp. 942-954

Carmen Keller and Alex Junghans

Volume 37, issue 7, 2017

An Overview of R in Health Decision Sciences pp. 735-746

Hawre Jalal, Petros Pechlivanoglou, Eline Krijkamp, Fernando Alarid-Escudero, Eva Enns and M. G. Myriam Hunink

A Review of Methods for Analysis of the Expected Value of Information pp. 747-758

Anna Heath, Ioanna Manolopoulou and Gianluca Baio

Using the Payoff Time in Decision-Analytic Models: A Case Study for Using Statins in Primary Prevention pp. 759-769

Alexander Thompson, Bruce Guthrie and Katherine Payne

Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy pp. 770-778

David van Klaveren, John B. Wong, David M. Kent and Ewout W. Steyerberg

A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models pp. 779-789

Edmund Jones, David Epstein and Leticia García-Mochón

Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models pp. 790-801

Natalia Olchanski, Joshua T. Cohen, Peter J. Neumann, John B. Wong and David M. Kent

Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves pp. 802-814

Ankur Pandya, Stephen Sy, Sylvia Cho, Sartaj Alam, Milton C. Weinstein and Thomas A. Gaziano

Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer pp. 815-826

Christine L. Barnett, Scott A. Tomlins, Daniel J. Underwood, John T. Wei, Todd M. Morgan, James E. Montie and Brian T. Denton

Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Transplantation: Results from Discrete Event Simulation pp. 827-843

Vibha C. A. Desai, Yann Ferrand, Teresa M. Cavanaugh, Christina M. L. Kelton, J. Jaime Caro, Jens Goebel and Pamela C. Heaton

Volume 37, issue 6, 2017

Handling Protest Responses in Contingent Valuation Surveys pp. 623-634

Mark Pennington, Manuel Gomes and Cam Donaldson

How Robust Are Value Judgments of Health Inequality Aversion? Testing for Framing and Cognitive Effects pp. 635-646

Shehzad Ali, Aki Tsuchiya, Miqdad Asaria and Richard Cookson

An Approach to Reconciling Competing Ethical Principles in Aggregating Heterogeneous Health Preferences pp. 647-656

Barry Dewitt, Alexander Davis, Baruch Fischhoff and Janel Hanmer

Using an Internet-Based Breast Cancer Risk Assessment Tool to Improve Social-Cognitive Precursors of Physical Activity pp. 657-669

Stephanie L. Fowler, William M. P. Klein, Linda Ball, Jaclyn McGuire, Graham A. Colditz and Erika A. Waters

Experienced Probabilities Increase Understanding of Diagnostic Test Results in Younger and Older Adults pp. 670-679

Bonnie Armstrong and Julia Spaniol

Choice Blindness and Health-State Choices among Adolescents and Adults pp. 680-687

Ernest H. Law, Annika L. Pickard, Anika Kaczynski and A. Simon Pickard

Providing Quantitative Information and a Nudge to Undergo Stool Testing in a Colorectal Cancer Screening Decision Aid: A Randomized Clinical Trial pp. 688-702

Peter H. Schwartz, Susan M. Perkins, Karen K. Schmidt, Paul F. Muriello, Sandra Althouse and Susan M. Rawl

“Naming and Framingâ€: The Impact of Labeling on Health State Values for Multiple Sclerosis pp. 703-714

Colin Green, Elizabeth Goodwin and Annie Hawton

The Potential of Collective Intelligence in Emergency Medicine: Pooling Medical Students’ Independent Decisions Improves Diagnostic Performance pp. 715-724

Juliane E. Kämmer, Wolf E. Hautz, Stefan M. Herzog, Olga Kunina-Habenicht and Ralf H. J. M. Kurvers

Utilization of Continuous “Spinners†to Communicate Risk pp. 725-729

Rachel F. Eyler, Sara Cordes, Benjamin R. Szymanski and Liana Fraenkel

Volume 37, issue 5, 2017

Estimating State Transitions for Opioid Use Disorders pp. 483-497

Emanuel Krebs, Jeong E. Min, Elizabeth Evans, Libo Li, Lei Liu, David Huang, Darren Urada, Thomas Kerr, Yih-Ing Hser and Bohdan Nosyk

Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction pp. 498-511

Ilias Goranitis, Joanna Coast, Ed Day, Alex Copello, Nick Freemantle and Emma Frew

Regulator Loss Functions and Hierarchical Modeling for Safety Decision Making pp. 512-522

Laura A. Hatfield, Christine M. Baugh, Vanessa Azzone and Sharon-Lise T. Normand

Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation Dynamics pp. 523-533

Sabine E. Grimm, Simon Dixon and John W. Stevens

The n-by-T Target Discharge Strategy for Inpatient Units pp. 534-543

Pratik J. Parikh, Nicholas Ballester, Kylie Ramsey, Nan Kong and Nancy Pook

A Randomized Trial of Expanding Choice Sets to Motivate Advance Directive Completion pp. 544-554

Katherine R. Courtright, Vanessa Madden, Nicole B. Gabler, Elizabeth Cooney, Jennifer Kim, Nicole Herbst, Lauren Burgoon, Jennifer Whealdon, Laura M. Dember and Scott D. Halpern

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France pp. 555-566

Christel Protiére, Rachel Baker, Dominique Genre, Anthony Goncalves and Patrice Viens

Prioritizing Rare Diseases: Psychological Effects Influencing Medical Decision Making pp. 567-576

Johanna Wiss, Lars-Ake Levin, David Andersson and Gustav Tinghög

Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis pp. 577-588

Richard W. Martin, Ryan D. Enck, Donald J. Tellinghuisen, Aaron T. Eggebeen, James D. Birmingham and Andrew J. Head

Evaluation of a Decision Aid for Women with Epilepsy Who Are Considering Pregnancy: A Randomized Controlled Trial pp. 589-599

Amanda McGrath, Louise Sharpe, Suncica Lah and Kaitlyn Parratt

Toward Optimal Decision Making among Vulnerable Patients Referred for Cardiac Surgery: A Qualitative Analysis of Patient and Provider Perspectives pp. 600-610

Ryan A. Gainer, Janet Curran, Karen J. Buth, Jennie G. David, Jean-Francois Légaré and Gregory M. Hirsch

Impact and Feasibility of Personalized Decision Support for Older Patients with Diabetes: A Pilot Randomized Trial pp. 611-617

Elbert S. Huang, Aviva G. Nathan, Jennifer M. Cooper, Sang Mee Lee, Na Shin, Priya M. John, William Dale, Nananda F. Col, David O. Meltzer and Marshall H. Chin

Volume 37, issue 4, 2017

Medical Decision Making and MDM Policy & Practice Reviewers, 2016 pp. 331-333

N/a

In Memoriam: Howard Raiffa, PhD — A Memoir and Personal Reflections pp. 334-336

Scott B. Cantor

Extrapolation of Survival Data in Cost-effectiveness Analyses: The Need for Causal Clarity pp. 337-339

Neil Hawkins and Richard Grieve

Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial pp. 340-352

Claire Williams, James D. Lewsey, Andrew H. Briggs and Daniel F. Mackay

Extrapolation of Survival Curves from Cancer Trials Using External Information pp. 353-366

Patricia Guyot, Anthony E. Ades, Matthew Beasley, Béranger Lueza, Jean-Pierre Pignon and Nicky J. Welton

Comment on: Decisional Conflict, Regret, and the Burden of Rational Decision Making pp. E360-E361

Anita D. Misra-Hebert and Michael W. Kattan

Response to “Comment on: Decisional Conflict, Regret, and the Burden of Rational Decision Making†pp. E362-E362

Andrew J. Vickers

Bayesian Solutions for Handling Uncertainty in Survival Extrapolation pp. 367-376

Miguel A. Negrín, Julian Nam and Andrew H. Briggs

Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods pp. 377-390

Christopher Jackson, John Stevens, Shijie Ren, Nick Latimer, Laura Bojke, Andrea Manca and Linda Sharples

Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients pp. 391-402

Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller and Henrik Støvring

You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses pp. 403-414

Rudolf T. Hoogenveen, Hendriek C. Boshuizen, Peter M. Engelfriet and Pieter H. M. van Baal

Using Survival Analysis to Improve Estimates of Life Year Gains in Policy Evaluations pp. 415-426

Rachel Meacock, Matt Sutton, Søren Kristensen and Mark Harrison

Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling pp. 427-439

Claire Williams, James D. Lewsey, Daniel F. Mackay and Andrew H. Briggs

Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease pp. 440-452

Maggie Tabberer, Sebastian Gonzalez-McQuire, Hana Muellerova, Andrew H. Briggs, Maureen P. M. H. Rutten- van Mölken, Mike Chambers and David A. Lomas

Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study pp. 453-468

Alex Exuzides, Chris Colby, Andrew H. Briggs, David A. Lomas, Maureen P. M. H. Rutten- van Mölken, Maggie Tabberer, Mike Chambers, Hana Muellerova, Nicholas Locantore, Nancy A. Risebrough, Afisi S. Ismaila and Sebastian Gonzalez-McQuire

Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model pp. 469-480

Andrew H. Briggs, Timothy Baker, Nancy A. Risebrough, Mike Chambers, Sebastian Gonzalez-McQuire, Afisi S. Ismaila, Alex Exuzides, Chris Colby, Maggie Tabberer, Hana Muellerova, Nicholas Locantore, Maureen P. M. H. Rutten� van Mölken and David A. Lomas

Volume 37, issue 3, 2017

Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer pp. 179-192

Ellen G. Engelhardt, Arwen H. Pieterse, Paul K. J. Han, Nanny van Duijn-Bakker, Frans Cluitmans, Ed Maartense, Monique M. E. M. Bos, Nir I. Weijl, Cornelis J. A. Punt, Patricia Quarles van Ufford-Mannesse, Harm Sleeboom, Johanneke E. A. Portielje, Koos J. M. van der Hoeven, F. J. Sherida Woei-A-Jin, Judith R. Kroep, Hanneke C. J. M. de Haes, Ellen M. A. Smets and Anne M. Stiggelbout

Side Effect Perceptions and Their Impact on Treatment Decisions in Women pp. 193-203

Erika A. Waters, Thorsten Pachur and Graham A. Colditz

Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk pp. 204-215

Glen B. Taksler, Adam T. Perzynski and Michael W. Kattan

Other Ways of Knowing pp. 216-229

Negin Hajizadeh, Melissa J. Basile, Andrzej Kozikowski, Meredith Akerman, Tara Liberman, Thomas McGinn and Michael A. Diefenbach

Subjective Numeracy and the Influence of Order and Amount of Audible Information on Perceived Medication Value pp. 230-238

Liana Fraenkel, Marilyn Stolar, Sarah Swift, Richard L. Street, Harjinder Chowdhary and Ellen Peters

Age Weights for Health Services Derived from the Relative Social Willingness-to-Pay Instrument pp. 239-251

Jeff Richardson, John McKie, Angelo Iezzi and Aimee Maxwell

Handling Regional Variation in Health State Preferences within a Country pp. 252-261

Eleanor M. Pullenayegum, Kelly M. Sunderland, Jeffrey A. Johnson and Feng Xie

Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments pp. 262-272

Kelvin K. W. Chan, Feng Xie, Andrew R. Willan and Eleanor M. Pullenayegum

Exploring Differences between TTO and DCE in the Valuation of Health States pp. 273-284

Angela Robinson, Anne E. Spencer, José Luís Pinto-Prades and Judith A. Covey

Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences pp. 285-297

Brendan Mulhern, Nick Bansback, Arne Hole and Aki Tsuchiya

The Role of Qualitative Research Methods in Discrete Choice Experiments pp. 298-313

Caroline Vass, Dan Rigby and Katherine Payne

Reliability, Validity, and Feasibility of Direct Elicitation of Children’s Preferences for Health States pp. 314-326

R. Trafford Crump, Lauren M. Beverung, Ryan Lau, Rita Sieracki and Mateo Nicholson

Volume 37, issue 2, 2017

Why Do Health Economists Promote Technology Adoption Rather Than the Search for Efficiency? A Proposal for a Change in Our Approach to Economic Evaluation in Health Care pp. 139-147

Graham Scotland and Stirling Bryan

How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants pp. 148-161

Rita Faria, Simon Walker, Sophie Whyte, Simon Dixon, Stephen Palmer and Mark Sculpher

Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework pp. 162-172

Isaac Corro Ramos, Stefan K. Lhachimi, Andreas Gerber-Grote and Maiwenn J. Al

Using CART to Identify Thresholds and Hierarchies in the Determinants of Funding Decisions pp. 173-182

Chris Schilling, Duncan Mortimer and Kim Dalziel

Markov Influence Diagrams pp. 183-195

Francisco J. Díez, Mar Yebra, Iñigo Bermejo, Miguel A. Palacios-Alonso, Manuel Arias Calleja, Manuel Luque and Jorge Pérez-Martín

A Markov Decision Process Model for Cervical Cancer Screening Policies in Colombia pp. 196-211

Raha Akhavan-Tabatabaei, Diana Marcela Sánchez and Thomas G. Yeung

Using Simulation to Model and Validate Invasive Breast Cancer Progression in Women in the Study and Control Groups of the Canadian National Breast Screening Studies I and II pp. 212-223

Sharareh Taghipour, Laurent N. Caudrelier, Anthony B. Miller and Bart Harvey

Progression and Transmission of HIV/AIDS (PATH 2.0) pp. 224-233

Chaitra Gopalappa, Paul G. Farnham, Yao-Hsuan Chen and Stephanie L. Sansom

Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients pp. 234-242

Patrizia Ferroni, Fabio Massimo Zanzotto, Noemi Scarpato, Silvia Riondino, Umberto Nanni, Mario Roselli and Fiorella Guadagni

Sensitivity Analysis in Sequential Decision Models pp. 243-252

Qiushi Chen, Turgay Ayer and Jagpreet Chhatwal

Understanding the Effects of Competition for Constrained Colonoscopy Services with the Introduction of Population-level Colorectal Cancer Screening pp. 253-263

Leslie Anne Campbell, John T. Blake, George Kephart, Eva Grunfeld and Donald MacIntosh

Determinants of Change in the Cost-effectiveness Threshold pp. 264-276

Mike Paulden, James O’Mahony and Christopher McCabe

Volume 37, issue 1, 2017

38th Annual Meeting of the Society for Medical Decision Making pp. E1-E334

N/a

Decisional Conflict, Regret, and the Burden of Rational Decision Making pp. 3-5

Andrew J. Vickers

In Search of Cognitive Dignity pp. 6-8

Paul Clay Sorum

The Role of Physicians’ First Impressions in the Diagnosis of Possible Cancers without Alarm Symptoms pp. 9-16

Olga Kostopoulou, Miroslav Sirota, Thomas Round, Shyamalee Samaranayaka and Brendan C. Delaney

The Influence of Varying Cost Formats on Preferences pp. 17-26

Charles Changchuan Jiang and Liana Fraenkel

The Phenomenology of the Diagnostic Process pp. 27-34

Norbert Donner-Banzhoff, Judith Seidel, Anna Maria Sikeler, Stefan Bösner, Maria Vogelmeier, Anja Westram, Markus Feufel, Wolfgang Gaissmaier, Odette Wegwarth and Gerd Gigerenzer

The Bifocal Lens Model and Equation pp. 35-45

Jason W. Beckstead

The Physician Recommendation Coding System (PhyReCS) pp. 46-55

Karen A. Scherr, Angela Fagerlin, Lillie D. Williamson, J. Kelly Davis, Ilona Fridman, Natalie Atyeo and Peter A. Ubel

Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions pp. 56-69

Karen A. Scherr, Angela Fagerlin, Timothy Hofer, Laura D. Scherer, Margaret Holmes-Rovner, Lillie D. Williamson, Valerie C. Kahn, Jeffrey S. Montgomery, Kirsten L. Greene, Biqi Zhang and Peter A. Ubel

Primary Care Physicians’ Support of Shared Decision Making for Different Cancer Screening Decisions pp. 70-78

Jennifer Elston Lafata, Richard F. Brown, Michael P. Pignone, Scott Ratliff and L. Aubree Shay

Mapping the Decision-Making Process for Adjuvant Endocrine Therapy for Breast Cancer pp. 79-90

Louise L. Beryl, Katharine A. S. Rendle, Meghan C. Halley, Katherine A. Gillespie, Suepattra G. May, Jennifer Glover, Peter Yu, Runi Chattopadhyay and Dominick L. Frosch

The Influence of Disease Severity of Preceding Clinical Cases on Pathologists’ Medical Decision Making pp. 91-100

Paul D. Frederick, Heidi D. Nelson, Patricia A. Carney, Tad T. Brunyé, Kimberly H. Allison, Donald L. Weaver and Joann G. Elmore

Accuracy of the Surgeons’ Clinical Prediction of Postoperative Major Complications Using a Visual Analog Scale pp. 101-112

John C. Woodfield, Peter M. Sagar, Dinesh K. Thekkinkattil, Praveen Gogu, Lindsay D. Plank and Dermot Burke

Exploring Provider Reactions to Decision Aid Distribution and Shared Decision Making pp. 113-126

Clarissa Hsu, David T. Liss, Dominick L. Frosch, Emily O. Westbrook and David Arterburn

Medical Decisions of Pediatric Residents Turn Riskier after a 24-Hour Call with No Sleep pp. 127-133

Adi Aran, Netanel Wasserteil, Itai Gross, Joseph Mendlovic and Yehuda Pollak

Author Index for Abstracts pp. E335-E359

N/a